From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Notes from Underground – Most read articles for the week ending Dec 14

By Darren Atwater | Sunday 15 December 2024


 


The most read non-Tom article last week is DG Innovate – “pleased to announce” placing, but how ‘pleasing’ is it really?… by Steve Moore at number 9 or number 9 including Bearcasts. 

The most-read ShareProphets articles this week were:

  1. DG Innovate – “pleased to announce” placing, but how ‘pleasing’ is it really?…
    Describing itself as an “advanced research and development company developing pioneering solutions in sustainable mobility and energy storage”, DG Innovate (DGI) “is pleased to announce… the company has conditionally raised £500,000 (before expenses)… at a price of 0.08 pence per ordinary share… The proceeds from the placing support the joint venture with EVage Automotive… and provide ongoing working capital”. Er, how comprehensively does £0.5 million before expenses do that though?

  2. Aptamer – share options and directors shares purchases announcements, attempted ramptastic?…
    Aptamer Group (APTA) has issued “Grant of Options and Director Fee Shares” and director share dealings announcements, and what of the shares currently responding more than 22% higher to 0.36p?

  3. BREAKING: Amazing Morepen video, the truth about Skins share sales, FYB with Optibiotix
    It is not the big story but Steve O’Hara has confirmed he has a sell order in on Skinbiotherapeutics (SBTX) shares. It’s been there for a while and shares are only sold inn small volumes on up days. Those who think that Optibiotix (OPTI) is either the only seller or a big seller are kidding themselves. On some days in recent weeks O’Hara has accounted for c6% of volumes on most days it has been nil

  4. Has nobody explained to Versarien owning gerbils what an RNS reach is? Nonsense deal announced
    I would ban RNS Reach announcements. These are announcements that are not deemed by a Nomad or advisor to be price sensitive, ones that do not flick the revenue dial more than an iota. So, they cannot go out as an RNS but must be a Reach, a marketing communication. Thus, companies such as Versarien (VRS) use them to ramp the shares with non news, believing (rightly) that their investors are too stupid to know what is going on.

  5. Inspecs – after as recently as September “confident in meeting market expectations”, now “improvement in Q4 sales not having been as strong as anticipated”. Uh oh!… Most recently on Inspecs Group (SPEC), describing itself as “a leading designer, manufacturer and distributor of eyewear”, in June with the shares down towards 60p I questioned how likely really is its guidance to be met and concluded suggesting significant trading improvement would be needed to justify the valuation and to still avoid/sell. The shares most recently closed at 48.5p and what about now a “Trading Update”?

  6. Chill Brands statement: does it have no idea at all about its cash position?
    This is taking the piss. The last time we knew Chill Brands’ (CHLL) cash position was at 30 September 2023. Here we are more than 14 months later and despite a statement today it still will not tell us. Surely it knows the number but its failure to report it tells you that it is essentially bugger all. The statement is grim and further vindication for those of us who faced criminal harassment for daring to expose this scam.

  7. Photo Article: a reader sends a Christmas present to the Welsh Hovel, I am going to be a Skins double Millionaire. Whatever..
    A kind reader sent me an early present as you can see below. Sadly not Metaxa, you all know where to send it folks, but a poster with some screws and stern instructions to hang it in my wood shed.

  8. An economics lesson for a restaurant in Warwickshire: price setting and price taking
    After weeks of badgering the restaurant where my siblings and I had a booking for 23 four days before Christmas finally came back with a Christmas menu. £28.50 for 2 courses, £33.50 for three. With thirsty eldest daughter Olaf among the 23, I reckon that, with drinks, we were looking at a bill of c£800. We cancelled and are now bringing our own food to the local Scout hut. I have some surplus booze from events here and so we are all sorted. The total cost will be under a ton. But the restaurant’s response was instructive as to the current climate.

  9. Eco Buildings Group proves modular housing business plan is working: STRONG BUY
    Eco Buildings (ECOB) has announced that in the 10 weeks since its modular housing solutions factory in Albania has started producing it has already generated revenues of €1,018,368, which should be on a 40% gross margin.

  10. Video: Skinbiotherapeutics FY Results Presentation
    The only Geordie I wish to see on video is called Cheryl. Sadly, she is not the boss at Skinbiotherapeutics (SBTX) as she’d be far less likely to arrange financings with proven fraudsters than Stuart Ashman. Anyhow Ashman and his grossly overpaid FD Manprick have recorded the video below. Notwithstanding this company’s management, I continue to regard the shares, at 16.75p, as very cheap and perfectly capable of trebling or indeed being a six bagger within 18 months. Enjoy. Or should that be, endure.

The most listened-to Bearcasts this week were:

  1. Tom Winnifrith Bearcast: Tom Winnifrith you are a prick tweeted the impoverished peasant
    I start with the arrival of the Yargs for distribution and more Christmas preparation, then Avacta (AVCT), Parkmead (PMG), Skinbiotherapeutics (SBTX), Amaroq (AMRQ) and a warning about Blackbird (BIRD) and there is news of a forthcoming cameo here by old mother Stacey.

  2. Tom Winnifrith Bearcast: I wish I knew what Luke Johnson was selling today, here are my two sell tips for Tim
    I look today at Victoria (VCP), Avacta (AVCT), MicroSalt (SALT), Skinbiotherapeutics (SBTX), Probiotix (PBX), Hydrogen Utopia (HUI), Supply@ME Capital (FRAUD) and a dead cat bounce, Wishbone Gold (WSBN) and its auditors and Valirx (VAL)

  3. Tom Winnifrith Bearcast: Be careful what you wish for
    I discuss the aftermath of Storm Darragh at the Welsh Hovel, a storm which left us with power cuts last night hence no bearcast. Then Syria, Kefi Gold & Copper (KEFI) and Skinbiotherapeutics (SBTX)

  4. Tom Winnifrith Bearcast: Is Euroloon Jonathan Price trying to kill me?? Evil Banksta even more conceited than usual today
    Tom I start with the Euroloon's cunning plan. Then it is Victoria (VCP), Equals (EQLS) and why there will be more takeovers in the UK, Skinbiotherapeutics (SBTX) and Optibiotix (OPTI)

  5. Tom Winnifrith Bearcast: no need to own retail or oil shares at all
    I start with Sterling then the state of the UK economy and the oil price. That leads me to the news about a bid for Tullow (TLW) and why that does not excite me and why I see no reasons to own any oil shares. Ditto retail and I explain why and comment on the bun fight at Boohoo.com (BOO). Finally Skinbiotherapeutics (SBTX) and Optibiotix (OPTI) the two companies that could herald goat farming by the end of 2025 and the news of yesterday afternoon.

  6. Tom Winnifrith Bearcast: is that a margin call I see Ms Binkowska?
    In today's podcast I look at collapsing Hydrogen Utopia (HUI), insolvent Technology Minerals (TM1), the curse of Cleverly riding again, and finally at Pantheon Resources (PANR), buy on the rumour, sell on the news?

  7. Tom Winnifrith bearcast: Ariana screwed by the Croc, why does Africa always feck it up?
    I discuss the Ariana (AAU) news from Zimbabwe

  8. Tom Winnifrith Bonus Bearcast: Hydrogen Utopia demolished and exposed via publicly available documents, where has the five hundred grand gone?
    This really is a bonus. The shares should be suspended as what you can ascertain from trawling public documents is that half a Bernie seems to have gone missing, the company has sat on bad news and it now faces a massive funding crisis. Nick Michaels at adviser Alfred Henry and the FCA should be all over this like a rash.
This story is available to all readers
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 16:21:00